Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04383470
Other study ID # COH-FIT
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date April 26, 2020
Est. completion date June 2022

Study information

Verified date May 2020
Source University of Padova
Contact Marco Solmi, MD
Phone +390498213829
Email marco.solmi@unipd.it
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Observational, cross-sectional, multi-center, multi-wave survey, assessing characteristics and predictors of physical and mental health as well as health behaviors during COVID-19 pandemic, targeting the general population (children, adolescents and adults).


Description:

In March 2020, the World Health Organization declared the COVID-19 (known as Coronavirus) virus a global pandemic. COVID-19 is a variant of coronavirus thought to originate in Wuhan province China. Up until April 7, 2020, as many as 1,346,299 individuals had confirmed COVID-19 infection, with already 74,679 deaths from COVID-19 complications.

The hypothesis of this study is that the physical and mental health of the general population and health care workers involved in the management of COVID-19 infected people is heavily affected by COVID-19, but that risk and protective factors exist.

Investigators plan to distribute 3 different surveys based on the age group. The first survey, COH-FIT-Adults/ (COH-FIT-A), will be distributed the general adult (age >/= 18 years old) population in North America, South America, Europe, Asia, Africa and Australia via an online link, making the general population aware of the project via public announcements, social media and regular media coverage outlets, or via specialized institutes and agencies (e.g., opinion research centers) that are capable of using a randomly selected, nationally representative sample (potentially funded by national / local grant applications). For the subgroup of adult health-care professionals, additionally, survey distribution mechanisms will be used that utilize medical professional organizations and associations, hospital and university anonymized channels.

Guardians of adolescents aged 14-17 years old will be asked to provide electronic consent for their adolescent to participate in the COH-FIT-AD survey after having taken the survey and being familiar with the questions, being informed that the one question having sexuality as the content will be omitted from the adolescent version. Guardians of children aged 6-13 years old will be able to review the survey questions that children would answer before electronically consenting to participate.


Recruitment information / eligibility

Status Recruiting
Enrollment 100000
Est. completion date June 2022
Est. primary completion date December 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 6 Years and older
Eligibility Inclusion Criteria:

- General population

- Consenting to the study (adults)

- Guardians consenting to study participation of children and adolescents

Exclusion Criteria:

- Not consenting to the study (adults)

- Not assenting to the study (children and adolescents)

- age < 6 years old

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Greece Aristotle University of Thessaloniki Thessaloníki

Sponsors (3)

Lead Sponsor Collaborator
University of Padova Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health

Country where clinical trial is conducted

Greece, 

Outcome

Type Measure Description Time frame Safety issue
Primary Mental health symptoms, well-being change from last 2 weeks before the pandemic to last 2 weeks during COVID-19 pandemic Primary outcome in the wave 1 survey, conducted during the COVID-19 pandemic, will be mean change in visual analogue scale-assessed transdiagnostic measures across all psychiatric symptoms, and World Health Organization (WHO)-5 well-being in the last 2 weeks compared to the last 2 weeks of "regular life" before the COVID-19 outbreak.
For WHO-5 the raw score ranges from 0 (absence of well-being) to 25 (maximal well-being).
wave 1 - change from last 2 weeks before pandemic to the following from April 26th 2020 on, until the pandemic will be over as declared by WHO (we estimate between October 2020 and April 2021)
Primary Mental health symptoms, well-being change from last 2 weeks before the pandemic to last 2 weeks 6 months after WHO declares pandemic over COVID-19 pandemic Primary outcome in the wave 2 survey, conducted during the COVID-19 pandemic, will be mean change in visual analogue scale-assessed transdiagnostic measures across all psychiatric symptoms and World Health Organization (WHO)-5 well-being in the last 2 weeks six months after the COVID-19 pandemic ended, compared to the last 2 weeks of "regular life" before the COVID-19 outbreak.
For WHO-5 the raw score ranges from 0 (absence of well-being) to 25 (maximal well-being).
wave 2 - change from before to 6 months after pandemic
Primary Mental health symptoms change, well-being change from last 2 weeks before the pandemic to last 2 weeks 12 months after WHO declares pandemic over COVID-19 pandemic Primary outcome in the wave 3 survey, conducted during the COVID-19 pandemic, will be mean change in visual analogue scale-assessed transdiagnostic measures across all psychiatric symptoms and World Health Organization (WHO)-5 well-being in the last 2 weeks 12 months after the COVID-19 pandemic ended, compared to the last 2 weeks of "regular life" before the COVID-19 outbreak.
For WHO-5 the raw score ranges from 0 (absence of well-being) to 25 (maximal well-being).
wave 3 - change from before to 12 months after pandemic (after the pandemic outbreak has been declared from WHO, and until the pandemic outbreak has been declared conlucded by WHO)
Secondary Change in alcohol abuse, as change in units used from last 2 weeks before the pandemic to last 2 weeks during pandemic Change in alcohol abuse, as change in units used from last 2 weeks before the pandemic to last 2 weeks during pandemic wave 1 - change from last 2 weeks before pandemic to the following from April 26th 2020 on, until the pandemic will be over as declared by WHO (we estimate between October 2020 and April 2021)
Secondary Change in cigarettes use, as change in number of cigarettes per day from last 2 weeks before the pandemic to last 2 weeks during pandemic Change in cigarettes use, as change in number of cigarettes per day from last 2 weeks before the pandemic to last 2 weeks during pandemic wave 1 - change from last 2 weeks before pandemic to the following from April 26th 2020 on, until the pandemic will be over as declared by WHO (we estimate between October 2020 and April 2021)
Secondary Change in grams of cannabinoids smoked from last 2 weeks before the pandemic to last 2 weeks during pandemic Change in grams of cannabinoids smoked from last 2 weeks before the pandemic to last 2 weeks during pandemic wave 1 - change from last 2 weeks before pandemic to the following from April 26th 2020 on, until the pandemic will be over as declared by WHO (we estimate between October 2020 and April 2021)
Secondary Change in alcohol abuse, as change in units used from last 2 weeks before the pandemic to last 2 weeks during pandemic Change in alcohol abuse, as change in units used from last 2 weeks before the pandemic to last 2 weeks during pandemic wave 2 - change from before to 6 months after pandemic
Secondary Change in cigarettes use, as change in number of cigarettes per day from last 2 weeks before the pandemic to last 2 weeks during pandemic Change in cigarettes use, as change in number of cigarettes per day from last 2 weeks before the pandemic to last 2 weeks during pandemic wave 2 - change from before to 6 months after pandemic
Secondary Change in grams of cannabinoids smoked from last 2 weeks before the pandemic to last 2 weeks during pandemic Change in grams of cannabinoids smoked from last 2 weeks before the pandemic to last 2 weeks during pandemic wave 2 - change from before to 6 months after pandemic
Secondary Change in alcohol abuse, as change in units used from last 2 weeks before the pandemic to last 2 weeks during pandemic Change in alcohol abuse, as change in units used from last 2 weeks before the pandemic to last 2 weeks during pandemic wave 3 - change from before to 12 months after pandemic
Secondary Change in cigarettes use, as change in number of cigarettes per day from last 2 weeks before the pandemic to last 2 weeks during pandemic Change in cigarettes use, as change in number of cigarettes per day from last 2 weeks before the pandemic to last 2 weeks during pandemic wave 3 - change from before to 12 months after pandemic
Secondary Change in grams of cannabinoids smoked from last 2 weeks before the pandemic to last 2 weeks during pandemic Change in grams of cannabinoids smoked from last 2 weeks before the pandemic to last 2 weeks during pandemic wave 3 - change from before to 12 months after pandemic
Secondary Change in general physical health, self-rated, on a VAS scale from 0 to 100. Change in general physical health, self-rated, on a VAS scale from 0 to 100. wave 1 - change from last 2 weeks before pandemic to the following from April 26th 2020 on, until the pandemic will be over as declared by WHO (we estimate between October 2020 and April 2021)
Secondary Change in general physical health, self-rated, on a VAS scale from 0 to 100. Change in general physical health, self-rated, on a VAS scale from 0 to 100. wave 2 - change from before to 6 months after pandemic
Secondary Change in general physical health, self-rated, on a VAS scale from 0 to 100. Change in general physical health, self-rated, on a VAS scale from 0 to 100. wave 3 - change from before to 12 months after pandemic
Secondary Change in general mental health, self-rated, on a VAS scale from 0 to 100. Change in general mental health, self-rated, on a VAS scale from 0 to 100. wave 1 - change from last 2 weeks before pandemic to the following from April 26th 2020 on, until the pandemic will be over as declared by WHO (we estimate between October 2020 and April 2021)
Secondary Change in general mental health, self-rated, on a VAS scale from 0 to 100. Change in general mental health, self-rated, on a VAS scale from 0 to 100. wave 2 - change from before to 6 months after pandemic
Secondary Change in general mental health, self-rated, on a VAS scale from 0 to 100. Change in general mental health, self-rated, on a VAS scale from 0 to 100. wave 3 - change from before to 12 months after pandemic
Secondary Change in easiness of access to care, self-rated a on a VAS scale from 0 to 100. Change in easiness of access to care, self-rated a on a VAS scale from 0 to 100. wave 1 - change from last 2 weeks before pandemic to the following from April 26th 2020 on, until the pandemic will be over as declared by WHO (we estimate between October 2020 and April 2021)
Secondary Change in easiness of access to care, self-rated a on a VAS scale from 0 to 100. Change in easiness of access to care, self-rated a on a VAS scale from 0 to 100. wave 2 - change from before to 6 months after pandemic
Secondary Change in easiness of access to care, self-rated a on a VAS scale from 0 to 100. Change in easiness of access to care, self-rated a on a VAS scale from 0 to 100. wave 3 - change from before to 12 months after pandemic
Secondary Change in medication adherence, self-rated a on a VAS scale from 0 to 100. Change in medication adherence, self-rated a on a VAS scale from 0 to 100. wave 1 - change from last 2 weeks before pandemic to the following from April 26th 2020 on, until the pandemic will be over as declared by WHO (we estimate between October 2020 and April 2021)
Secondary Change in medication adherence, self-rated a on a VAS scale from 0 to 100. Change in medication adherence, self-rated a on a VAS scale from 0 to 100. wave 2 - change from before to 6 months after pandemic
Secondary Change in medication adherence, self-rated a on a VAS scale from 0 to 100. Change in medication adherence, self-rated a on a VAS scale from 0 to 100. wave 3 - change from before to 12 months after pandemic
Secondary Change in functioning in self-care, school/work, social, and family, self-rated a on a VAS scale from 0 to 100. Change in functioning in self-care, school/work, social, and family, self-rated a on a VAS scale from 0 to 100. wave 1 - change from last 2 weeks before pandemic to the following from April 26th 2020 on, until the pandemic will be over as declared by WHO (we estimate between October 2020 and April 2021)
Secondary Change in functioning in self-care, school/work, social, and family, self-rated a on a VAS scale from 0 to 100. Change in functioning in self-care, school/work, social, and family, self-rated a on a VAS scale from 0 to 100. wave 2 - change from before to 6 months after pandemic
Secondary Change in functioning in self-care, school/work, social, and family, self-rated a on a VAS scale from 0 to 100. Change in functioning in self-care, school/work, social, and family, self-rated a on a VAS scale from 0 to 100. wave 3 - change from before to 12 months after pandemic
See also
  Status Clinical Trial Phase
Completed NCT05130944 - Feasibility of Community Psychosocial Intervention for Women N/A
Recruiting NCT06079853 - Nurse Suicide: Physiologic Sleep Health Promotion Trial N/A
Completed NCT05490979 - The Impact of Dyad Exercises on Well-being and Connection in Young Adults N/A
Not yet recruiting NCT05963893 - Promoting a Healthy Life Through Gender Equity
Completed NCT03849924 - Enhancing One's Sense of Self Using Self-Affirmation N/A
Active, not recruiting NCT05541653 - The IGNITE Study on Concentrated Investment in Black Neighborhoods N/A
Completed NCT03303326 - Arab American Women's Health Study N/A
Not yet recruiting NCT05542537 - Nurturing Healthy Teachers N/A
Completed NCT02785471 - Assessing Online Interventions for Men's' Mental Health and Wellbeing N/A
Completed NCT02683811 - Effectiveness of the Updated Version of the School-based Program Diario Della Salute (DDS-2) N/A
Withdrawn NCT05605028 - A Mental Health Intervention for a Community Program Called the PowerObesity N/A
Not yet recruiting NCT04537676 - Patient Empowerment Study
Recruiting NCT06324318 - Parenting in 2 Worlds Multisite Trial Phase 2
Completed NCT05455905 - Voice Biomarkers Predictive of Depression and Anxiety
Completed NCT03368014 - "Fun.Feel.Share" Lyrics-writing and Singing Show N/A
Completed NCT05109923 - Onnit Labs New Mood Supplementation in Healthy College Students N/A
Not yet recruiting NCT05825040 - Randomized Controlled Trial on Precision Mental Health N/A
Not yet recruiting NCT06023342 - Examining Engagement Predictors of Health and Fitness App Uptake and Subscription in the General Population
Completed NCT06044363 - Satir Model for Self-esteem, Mental Health, and Family Function Among Individuals With Substance Use Disorders N/A
Recruiting NCT04790162 - Heartfulness Meditation to Improve Resilience Among Health Care Students: A 90 Day Program N/A

External Links